A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

NCT00545207 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Post-Menopausal Osteopenia

Interventions

DRUG: ibandronate [Bonviva/Boniva]
DRUG: Placebo

Sponsor

Hoffmann-La Roche